Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute leukaemia patients receiving bortezomib-containing chemotherapy

about

Bortezomib resistance in multiple myeloma is associated with increased serine synthesis.(Immuno)proteasomes as therapeutic target in acute leukemia.Proteasome dysregulation in human cancer: implications for clinical therapies.The Influence of Metabolism on Drug Response in Cancer

P2860

Q41554672-52CCD7D8-F6B9-4E72-A986-921D7F3540EA Q47131929-0F156C78-E936-4DF0-9301-49F43D40668C Q50077966-52290EA4-5F29-496C-B012-9B893E0C2151 Q59136910-7D9DD8FA-EC9A-4005-B54D-12E4806A29D6

P2860

Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute leukaemia patients receiving bortezomib-containing chemotherapy

Item

http://www.wikidata.org/entity/Q37233146

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 06 September 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Proteasome subunit expression ...... ezomib-containing chemotherapy

@en

Proteasome subunit expression ...... zomib-containing chemotherapy.

@nl

type

Item

label

Proteasome subunit expression ...... ezomib-containing chemotherapy

@en

Proteasome subunit expression ...... zomib-containing chemotherapy.

@nl

prefLabel

Proteasome subunit expression ...... ezomib-containing chemotherapy

@en

Proteasome subunit expression ...... zomib-containing chemotherapy.

@nl

P1476

Proteasome subunit expression ...... ezomib-containing chemotherapy

@en

P2093

Denise Niewerth

http://www.w3.org/2001/XMLSchema#string

Gaye Jenkins

http://www.w3.org/2001/XMLSchema#string

Gerrit Jansen

http://www.w3.org/2001/XMLSchema#string

Gertjan J L Kaspers

http://www.w3.org/2001/XMLSchema#string

Jacqueline Cloos

http://www.w3.org/2001/XMLSchema#string

James A Whitlock

http://www.w3.org/2001/XMLSchema#string

Johan van Meerloo

http://www.w3.org/2001/XMLSchema#string

Peter M van de Ven

http://www.w3.org/2001/XMLSchema#string

Sonja Zweegman

http://www.w3.org/2001/XMLSchema#string

Terzah M Horton

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of a new series of non-covalent proteasome inhibitors with exquisite potency and selectivity for the 20S β5-subunit

The immunoproteasome in antigen processing and other immunological functions

Phase 1 trial of the proteasome inhibitor bortezomib and pegylated liposomal doxorubicin in patients with advanced hematologic malignancies.

Phase II study of single-agent bortezomib for the treatment of patients with fludarabine-refractory B-cell chronic lymphocytic leukemia.

Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma.

Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study.

Bortezomib with chemotherapy is highly active in advanced B-precursor acute lymphoblastic leukemia: Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study.

A Phase 2 study of bortezomib combined with either idarubicin/cytarabine or cytarabine/etoposide in children with relapsed, refractory or secondary acute myeloid leukemia: a report from the Children's Oncology Group

Pilot study of bortezomib for patients with imatinib-refractory chronic myeloid leukemia in chronic or accelerated phase.

Clinical and pharmacodynamic activity of bortezomib and decitabine in acute myeloid leukemia.

P2888

s13045-016-0312-z

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13045-016-0312-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Stephen P Hunger

P577

2016-09-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1027910018

http://www.w3.org/2001/XMLSchema#string

P698

27599459

http://www.w3.org/2001/XMLSchema#string

P921

leukemia

chemotherapy

P932

5011854

http://www.w3.org/2001/XMLSchema#string

Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute leukaemia patients receiving bortezomib-containing chemotherapy

about

P2860

P2860

Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute leukaemia patients receiving bortezomib-containing chemotherapy

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P932